title: [Surgical treatment of Siewert II adenocarcinoma of the esophagogastric junction].
abstract: OBJECTIVE
  To explore the outcomes after surgical treatment of esophagogastric junction carcinoma (EGJC).
  
  
  METHODS
  One hundred and eighty-five patients with EGJC undergoing surgery from October 2000 to September 2006 at the Cancer Hospital of Shantou University were reviewed retrospectively. The clinical outcomes were compared between transthoracic and transabdominal approach.
  
  
  RESULTS
  Of the 185 patients, 133 underwent operation via transthoracic approach and 52 via transabdominal approach. The postoperative complication rates were 10.5%(14/133) and 11.5%(6/52) and the 1-, 3-, 5-year overall survival rates were 83.9%, 44.5%, 32.9% and 86.0%, 38.0%, 30.0% in transthoracic and transabdominal groups respectively, and the difference were not statistically significant (both P>0.05).
  
  
  CONCLUSIONS
  Surgical approach should be individualized for EGCJ.
authors.affiliation: Department of Thoracic Surgery, Cancer Hospital, Shantou University, Shantou, China. 13923993919@139.com
authors.forename: Yun-sheng
authors.initials: YS
authors.lastname: Qin
authors.forename: Ye-zhong
authors.initials: YZ
authors.lastname: Zhuang
authors.forename: Jie-sheng
authors.initials: JS
authors.lastname: Yang
authors.forename: Chu-jian
authors.initials: CJ
authors.lastname: Huang
authors.forename: Qiang-zhou
authors.initials: QZ
authors.lastname: Xu
authors.forename: Mian-sheng
authors.initials: MS
authors.lastname: Huang
mesh_terms: D000230:Adenocarcinoma / Q000601:surgery*; D000368:Aged; D004943:Esophagogastric Junction; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016896:Treatment Outcome